SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)

Clinical trial NCT00409539 · COMPLETED

Trial details

NCT number: NCT00409539
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Overactive Bladder Syndrome (OABS)

Start date: 2006-12-01
Primary completion: 2008-06-01
Enrollment: 550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.